BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36515454)

  • 21. Prion protein-dependent regulation of p53-MDM2 crosstalk during endoplasmic reticulum stress and doxorubicin treatments might be essential for cell fate in human breast cancer cell line, MCF-7.
    Tuğrul B; Balcan E; Öztel Z; Çöllü F; Gürcü B
    Exp Cell Res; 2023 Aug; 429(1):113656. PubMed ID: 37245583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
    Díaz-Chávez J; Fonseca-Sánchez MA; Arechaga-Ocampo E; Flores-Pérez A; Palacios-Rodríguez Y; Domínguez-Gómez G; Marchat LA; Fuentes-Mera L; Mendoza-Hernández G; Gariglio P; López-Camarillo C
    PLoS One; 2013; 8(5):e64378. PubMed ID: 23724044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.
    Raza S; Ohm JE; Dhasarathy A; Schommer J; Roche C; Hammer KD; Ghribi O
    Mol Cell Biochem; 2015 Dec; 410(1-2):187-95. PubMed ID: 26350565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of HCCR-1 and Bax in breast cancer.
    Meng K; Yuan G; Bao H; Wang L; Ma R; Yu B; Zhao S
    J BUON; 2019; 24(3):1027-1037. PubMed ID: 31424657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic suppression of prostatic cancer cells by coexpression of both murine double minute 2 small interfering RNA and wild-type p53 gene in vitro and in vivo.
    Ji K; Wang B; Shao YT; Zhang L; Liu YN; Shao C; Li XJ; Li X; Hu JD; Zhao XJ; Xu DQ; Li Y; Cai L
    J Pharmacol Exp Ther; 2011 Jul; 338(1):173-83. PubMed ID: 21444629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer.
    Xiong J; Li J; Yang Q; Wang J; Su T; Zhou S
    Breast Cancer Res; 2017 Mar; 19(1):27. PubMed ID: 28274247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 molecular imaging for the prediction of chemotherapeutic sensitivity in human breast cancer xenograft.
    Fu P; Sun L; Cao X; Li L; Zhao C
    Mol Imaging; 2014; 13():. PubMed ID: 25022573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of KDR expression induces apoptosis in breast cancer cells.
    Zhang X; Ge YL; Zhang SP; Yan P; Tian RH
    Cell Mol Biol Lett; 2014 Dec; 19(4):527-41. PubMed ID: 25182240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDM2 and PSMA Play Inhibitory Roles in Metastatic Breast Cancer Cells Through Regulation of Matrix Metalloproteinases.
    Bradbury R; Jiang WG; Cui YX
    Anticancer Res; 2016 Mar; 36(3):1143-51. PubMed ID: 26977010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA interference against MDM2 suppresses tumor growth and metastasis in pancreatic carcinoma SW1990HM cells.
    Shi W; Meng Z; Chen Z; Hua Y; Gao H; Wang P; Lin J; Zhou Z; Luo J; Liu L
    Mol Cell Biochem; 2014 Feb; 387(1-2):1-8. PubMed ID: 22200978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding.
    Park EY; Woo Y; Kim SJ; Kim DH; Lee EK; De U; Kim KS; Lee J; Jung JH; Ha KT; Choi WS; Kim IS; Lee BM; Yoon S; Moon HR; Kim HS
    Int J Biol Sci; 2016; 12(12):1555-1567. PubMed ID: 27994519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of p53 by novel MDM2 inhibitors: implications for pancreatic cancer therapy.
    Azmi AS; Philip PA; Aboukameel A; Wang Z; Banerjee S; Zafar SF; Goustin AS; Almhanna K; Yang D; Sarkar FH; Mohammad RM
    Curr Cancer Drug Targets; 2010 May; 10(3):319-31. PubMed ID: 20370686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol Induces Apoptosis and Attenuates Proliferation of MCF-7 Cells in Combination with Radiation and Hyperthermia.
    Amini P; Nodooshan SJ; Ashrafizadeh M; Eftekhari SM; Aryafar T; Khalafi L; Musa AE; Mahdavi SR; Najafi M; Farhood B
    Curr Mol Med; 2021; 21(2):142-150. PubMed ID: 32436827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Mdm2 sensitizes human retinal pigment epithelial cells to apoptosis.
    Bhattacharya S; Ray RM; Chaum E; Johnson DA; Johnson LR
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3368-80. PubMed ID: 21345989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects and mechanism of downregulation of COX‑2 expression by RNA interference on proliferation and apoptosis of human breast cancer MCF‑7 cells.
    Han H; Yang S; Lin SG; Xu CS; Han ZH
    Mol Med Rep; 2014 Dec; 10(6):3092-8. PubMed ID: 25323004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
    Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
    Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
    Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
    Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
    Brekman A; Singh KE; Polotskaia A; Kundu N; Bargonetti J
    Breast Cancer Res; 2011 Jan; 13(1):R3. PubMed ID: 21223569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
    Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
    Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.